News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,549 Results
Type
Article (85972)
Company Profile (650)
Press Release (751927)
Section
Business (232436)
Career Advice (4122)
Deals (39696)
Drug Delivery (127)
Drug Development (90807)
Employer Resources (195)
FDA (18018)
Job Trends (17299)
News (395906)
Policy (39654)
Tag
Academia (2979)
Alliances (56691)
Alzheimer's disease (1420)
Approvals (17982)
Artificial intelligence (236)
Bankruptcy (399)
Best Places to Work (12616)
Biotechnology (447)
Breast cancer (236)
Cancer (1808)
Cardiovascular disease (147)
Career advice (3524)
CAR-T (137)
Cell therapy (395)
Clinical research (72557)
Collaboration (712)
Compensation (377)
COVID-19 (2833)
C-suite (173)
Data (1669)
Diabetes (218)
Diagnostics (6815)
Earnings (95346)
Employer resources (167)
Events (128220)
Executive appointments (586)
FDA (18953)
Funding (636)
Gene therapy (283)
GLP-1 (760)
Government (5079)
Healthcare (20811)
Infectious disease (2949)
Inflammatory bowel disease (135)
Interviews (810)
IPO (17762)
Job creations (5183)
Job search strategy (2859)
Layoffs (517)
Legal (10075)
Lung cancer (269)
Manufacturing (264)
Medical device (14488)
Medtech (14493)
Mergers & acquisitions (22281)
Metabolic disorders (609)
Neuroscience (1866)
NextGen: Class of 2025 (7662)
Non-profit (5074)
Northern California (2134)
Obesity (340)
Opinion (260)
Patents (171)
People (64748)
Phase I (22388)
Phase II (31523)
Phase III (23724)
Pipeline (736)
Postmarket research (3550)
Preclinical (10040)
Radiopharmaceuticals (261)
Rare diseases (354)
Real estate (7381)
Regulatory (26361)
Research institute (2644)
Resumes & cover letters (649)
Southern California (1832)
Startups (4282)
United States (19553)
Vaccines (714)
Weight loss (255)
Date
Today (18)
Last 7 days (634)
Last 30 days (2733)
Last 365 days (36603)
2025 (4673)
2024 (37554)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1267)
Arizona (245)
Asia (49745)
Australia (8772)
California (4974)
Canada (1740)
China (417)
Colorado (227)
Connecticut (241)
Europe (113906)
Florida (705)
Georgia (173)
Illinois (524)
Indiana (273)
Maryland (801)
Massachusetts (3866)
Michigan (211)
Minnesota (356)
New Jersey (1405)
New York (1403)
North Carolina (976)
Northern California (2134)
Ohio (179)
Pennsylvania (1129)
South America (1649)
Southern California (1832)
Texas (736)
Utah (147)
Washington State (506)
838,549 Results for "adicet bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025
·
1 min read
Press Releases
Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones
January 8, 2025
·
7 min read
Press Releases
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 31, 2025
February 2, 2025
·
2 min read
Press Releases
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
February 5, 2025
·
4 min read
Press Releases
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
December 18, 2024
·
6 min read
Biotech Bay
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 5-6, 2024 in New York.
May 29, 2024
·
1 min read
Biotech Bay
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - June 28, 2024
Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced it granted inducement awards on June 28, 2024.
June 28, 2024
·
2 min read
FDA
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
Adicet Bio, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for the potential treatment of relapsed/refractory class III or class IV lupus nephritis.
June 5, 2024
·
4 min read
Press Releases
Adicet Bio to Participate in Upcoming Investor Conferences
November 1, 2024
·
1 min read
Press Releases
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - December 31, 2024
January 1, 2025
·
1 min read
1 of 83,855
Next
